FINWIRES · TerminalLIVE
FINWIRES

CSX Turnaround Going Well, but Valuation Looks Stretched, Morgan Stanley Says

By

CSX (CSX) stands to gain from an improving industry cycle, but the positives appear to be reflected in its current stock price, creating an unfavorable risk-reward profile, Morgan Stanley said in a Thursday note.

The company's turnaround is going well, with a "decent" Q1 earnings beat and a modest increase to full-year guidance, Morgan Stanley analysts said.

The leadership team has successfully boosted operational efficiency, as well as built a pipeline of 600 new projects to fill new capacity, the analysts said.

CSX stock has been significantly outperforming peers year to date, with gains of 19% compared with the group average of 10%, and over the last 12 months, with gains of 55% compared with 26%, while its valuation is the most expensive in its group, according to the note.

Trucking is expected to increasingly challenge railroads in the current cycle, while other railroad firms, particularly Canadian ones, offer a better risk-reward profile, the analysts said.

Morgan Stanley downgraded the company's stock to underweight from equal-weight and kept the price target at $30.

Price: $46.14, Change: $+2.96, Percent Change: +6.86%

Related Articles

Wire

New Hope Completes AU$300 Million Convertible Notes Offering

New Hope (ASX:NHC) completed a AU$300 million issuance of 2.625% senior unsecured convertible notes due 2032 and the concurrent repurchase of AU$293.3 million of its existing 2029 convertible notes, according to a Thursday filing with the Australian bourse.The new notes are expected to be listed on the Singapore Exchange Securities Trading on or around Thursday, per the filing.The repurchased 2029 notes, which account for around 98% of the outstanding notes, will be cancelled under their terms, the filing said. The company also plans to redeem the remaining AU$6.7 million of notes at par plus accrued interest prior to maturity.

ASX:NHC
Wire

Telix Pharmaceuticals Settles Issue of $600 Million Convertible Notes

Telix Pharmaceuticals (ASX:TLX) said it settled the issue of $600 million in 1.50% convertible notes due 2031, according to a Thursday Australian bourse filing.The convertible notes are expected to be listed on the Official List of the Singapore Exchange Securities Trading on Thursday.In the same filing, the company said that the repurchase of around AU$637 million in principal of the AU$650 million worth of 2.375% convertible bonds due 2029 is "substantially complete."After the repurchase, given that less than 15% in aggregate principal amount of the existing bonds will remain outstanding, Telix said it plans to exercise its right to repurchase and cancel all of the remaining existing bonds at their principal amount.

ASX:TLX
Wire

Century Communities Q1 Adjusted Earnings, Revenue Fall

Century Communities (CCS) reported Q1 adjusted earnings late Wednesday of $0.88 per diluted share, down from $1.39 a year earlier.Three analysts polled by FactSet expected $0.59.Revenue for the three months ended March 31 fell to $789.7 million from $903.2 million a year earlier.Four analysts surveyed by FactSet expected $807.7 million.

$CCS